BIIB BIOGEN INC.
NEUTRAL
Impact: 3/10
8-K
8-K context-dependent: Items 5.02
Final — all horizons settled through T+60d
BIIB ▲ +6.11% at T+60d
NEUTRAL call ✓ call won +6.11% · α vs SPY -4.59% · entry $184.10 → $195.34
Currently $199.10 · +8.15% from $184.10 entry
T+1d
-1.69%
call -1.69% · α -1.10%
$180.98
settled 3mo ago
T+5d
-0.66%
call -0.66% · α +0.32%
$182.88
settled 3mo ago
T+20d
-6.11%
call -6.11% · α -8.08%
$172.86
settled 2mo ago
T+60d
+6.11%
call +6.11% · α -4.59%
$195.34
settled 5d ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable. The filing is an 8-K with Item 5.02 disclosed, indicating a departure or appointment of directors or officers at Biogen Inc. (BIIB), but no details are available to assess the nature, participants, or implications of the change.
Actionable Insight
Monitor for supplemental disclosures or press releases from Biogen regarding leadership changes. Absent details, this event should not drive trading decisions.
Key Facts
- Filing type is 8-K, indicating a material event.
- Item 5.02 reported: Departure or appointment of directors or officers.
- No document content available to determine who was involved, whether it was a resignation, retirement, or termination, or if a replacement was named.
Financial Impact
Not specified
Risk Factors
- Potential for unexpected executive turnover if the departure was involuntary or involved C-suite executives.
- Lack of transparency due to unavailable filing content limits ability to assess governance stability.
Market Snapshot
Exchange
Nasdaq
Analyst Consensus
47% bullish (43 analysts)
Documents Analyzed
Report based on filing metadata.
23 reports for BIIB
92%
Hit rate
best @ T+60▲ +18.00%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 8, 2026
1d ago
|
ANALYST-UPGRADE
| $194.60 awaiting T+1 | awaiting T+1 | — | $199.10 (+2.31%) |
|
Jun 4, 2026
5d ago
|
Press Release
| $195.82 $195.30 | ▼ −0.27% | ▲ +2.33% | $199.10 (+1.68%) |
|
Jun 1, 2026
8d ago
|
Press Release
| $192.22 $188.66 | ▼ −1.85% | ▼ −2.00% | $199.10 (+3.58%) |
|
May 31, 2026
9d ago
|
ANALYST-UPGRADE
| $156.63 $154.99 | ▼ −1.05% | ▼ −1.18% | $199.10 (+27.12%) |
|
May 22, 2026
18d ago
|
ANALYST-UPGRADE
| $190.12 $187.84 | ▼ −1.20% | ▼ −0.81% | $199.10 (+4.72%) |
|
May 21, 2026
19d ago
|
Press Release
| $193.85 $193.07 | ▲ +0.40% | ▲ +0.99% | $199.10 (−2.71%) |
|
May 20, 2026
20d ago
|
ANALYST-UPGRADE
| $183.33 $185.18 | ▲ +1.01% | ▲ +1.66% | $199.10 (+8.60%) |
|
May 14, 2026
26d ago
|
ANALYST-UPGRADE
| $178.76 $180.47 | ▲ +0.96% | ▲ +0.18% | $199.10 (+11.38%) |
|
May 14, 2026
26d ago
|
Press Release
| $191.26 $192.32 | ▲ +0.55% | ▲ +1.78% | $199.10 (+4.10%) |
|
May 14, 2026
26d ago
|
8-K
| $191.26 $192.32 | ▲ +0.55% | ▲ +1.78% | $199.10 (+4.10%) |
Showing 10 of 23
US Market Status
Market Closed — Opens Thu (10h 59m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access